Nexalin Technology, Inc. (NXL)
- Sector
- Healthcare
- Industry
- Medical Devices
- Last price
- $1.50
- As of
Kresmion compiles this page from NXL's SEC filings, its 13F institutional holders and the market events Kresmion detects, each linked to its source.
Nexalin Technology, Inc. (NXL): no institutional manager tracked by Kresmion reported a non-option position in the latest Form 13F reporting quarter, and the most recent SEC filing on record for the company is a Form 10-Q filed 2026-11-12.
See the full NXL dossier
Price with insider and filing markers, who is positioning, fundamentals and peers for NXL on one page. Preview it with sample data, then open it live with a free account.
Preview the NXL dossierActive events for NXL
- mediumEarnings below estimates
Q3-2026: Missed consensus by 16.7%, EPS $-3.43 vs $-2.9391 estimate
- mediumEarnings below estimates
Q2-2026: Missed consensus by 8.9%, EPS $-3.30 vs $-3.03 estimate
- high13F: large increase
CITADEL ADVISORS LLC added +144% to NXL (2026Q2)
- high13F: large reduction
RENAISSANCE TECHNOLOGIES LLC cut 91% of NXL (2026Q1)
- mediumEarnings below estimates
Q3-2025: Missed consensus by 7.3% - EPS $-0.13 vs $-0.1212 estimate
FREE, NO ACCOUNT
Every event on NXL, as it fires
You are seeing 5 of 9 events recorded on NXL since 2026-05-31.
The five above landed across 5 days. The other 4 were recorded on 1 other days.
No fixed schedule: it goes out when the data has something in it. Unsubscribe anytime. We never sell your data.
No non-option holdings from tracked managers in this reporting quarter. Other reporting quarters are linked above.
Recent SEC filings, NXL
- 10-QSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 8-KSEC EDGAR ↗
- 10-QSEC EDGAR ↗
Going concern statement
NXL's 10-Q filed Nov 12, 2026 states:
These conditions raise substantial doubt about the Company's ability to continue as a going concern.
Read the 10-Q on SEC EDGAR Every company with a going concern statement
More data on NXL
NXL against its peers
NXL's operating margin of -2781.7% ranks in the 26th percentile of 16 Medical Devices sub-industry peers, fiscal periods ending between 2025-09-30 and 2026-07-31.
| Metric | NXL | Peer median | Percentile | n |
|---|---|---|---|---|
| Revenue FY | 301647 USD | 3.7M USD | 24 | 18 |
| Revenue YoY | n/a | -14.4% | n/a | 7 |
| Gross margin | 79.7% | 59.8% | 72 | 15 |
| Operating margin | -2781.7% | -243.6% | 26 | 16 |
| Net margin | -2725.8% | -318.4% | 25 | 17 |
| Return on equity | -219.4% | -227.3% | 53 | 15 |
| 1 year | -95.0% | -89.8% | 23 | 14 |
Peers (22): VYCO, ESMC, ADGM, NUWE, BTCY, CODX, VTAK, RMSL, IVF, BJDX, AIDX, BDMD, ODYY, POAS, AMIX, ICCM, VVOS, NUMD, LUDG, XAIR, WOK, TNON. Left out: FZMD (period gap), CSDX (no annual filing), PMEDF (period gap). Fiscal periods ending between 2025-09-30 and 2026-07-31. Every figure is one full fiscal year read from one annual filing (NXL: 10-K), reported in USD. Nothing is trailing twelve months and nothing is converted between currencies. Source: SEC EDGAR XBRL company facts (public domain); prices from Kresmion's daily equity market-data snapshot. Open the full comparison.
Cite this data
Kresmion counts the managers it follows that reported a non-option position in NXL on Form 13F-HR for the latest reporting quarter, orders those positions by the value each filing reports, and lists the company's latest SEC filings and the events Kresmion recorded on NXL in the last 180 days.
Upstream: SEC EDGAR filings for NXL
Kresmion, "Nexalin Technology, Inc. (NXL) institutional holdings and SEC filings", data as of 2026-11-13, https://kresmion.com/research/NXL. Upstream data: SEC EDGAR filings for NXL.
Link to this data (HTML):
<a href="https://kresmion.com/research/NXL">Nexalin Technology, Inc. (NXL) institutional holdings and SEC filings (Kresmion)</a>
Writing about this? Press contact and ready-to-quote figures
Follow NXL on a live board
Kresmion is a source-first market terminal for cross-asset market intelligence. Open a board scoped to NXL for its filings, 13F changes, insider trades, options positioning, and confluence read in one view, each with its source.